Mark E. Dmytruk - 01 Feb 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role: Chief Financial Officer
Signature: /s/ Karen Tepichin, Attorney-in-Fact
Issuer symbol: DNA
Transactions as of: 01 Feb 2024
Net transactions value: -$47,799
Form type: 4
Filing time: 06 Feb 2024, 17:06:34 UTC
Previous filing: 05 Jan 2024
Next filing: 06 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DNA	Class A Common Stock	Options Exercise		+65,448	+9.1%		781,546	01 Feb 2024	Direct	F1
transaction	DNA	Class A Common Stock	Options Exercise		+18,125	+2.3%		799,671	01 Feb 2024	Direct	F1
transaction	DNA	Class A Common Stock	Options Exercise		+1,635	+0.2%		801,306	01 Feb 2024	Direct	F2, F3
transaction	DNA	Class A Common Stock	Sale	$47,799	-39,569	-4.9%	$1.21	761,737	02 Feb 2024	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNA	Restricted Stock Units	Options Exercise		-65,448	-7.2%		843,335	01 Feb 2024	Class A Common Stock	65,448		Direct	F1
transaction	DNA	Restricted Stock Units	Options Exercise		-18,125	-2.6%		670,625	01 Feb 2024	Class A Common Stock	18,125		Direct	F1, F5
transaction	DNA	Class B Common Stock	Options Exercise		-1,635	-0.26%		631,957	01 Feb 2024	Class A Common Stock	1,635		Direct	F2, F3, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person.
F2	Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock.
F3	Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
F4	Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F5	The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
F6	Includes shares of Class B Common Stock that are subject to vesting conditions.

Remarks:

Chief Financial Officer